Medpace Holdings, Inc.
MEDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10,285 | $9,417 | $6,880 | $7,805 |
| - Cash | $669 | $245 | $28 | $461 |
| + Debt | $150 | $142 | $189 | $131 |
| Enterprise Value | $9,765 | $9,314 | $7,040 | $7,475 |
| Revenue | $2,109 | $1,886 | $1,460 | $1,142 |
| % Growth | 11.8% | 29.2% | 27.8% | – |
| Gross Profit | $656 | $525 | $432 | $328 |
| % Margin | 31.1% | 27.8% | 29.6% | 28.7% |
| EBITDA | $476 | $363 | $301 | $220 |
| % Margin | 22.6% | 19.3% | 20.6% | 19.2% |
| Net Income | $404 | $283 | $245 | $182 |
| % Margin | 19.2% | 15% | 16.8% | 15.9% |
| EPS Diluted | 12.63 | 8.88 | 7.28 | 4.81 |
| % Growth | 42.2% | 22% | 51.4% | – |
| Operating Cash Flow | $609 | $433 | $388 | $263 |
| Capital Expenditures | -$37 | -$37 | -$37 | -$28 |
| Free Cash Flow | $572 | $397 | $351 | $235 |